Teucrium polium in prevention of steatohepatitis in rats

被引:13
作者
Amini, Rahim [1 ]
Nosrati, Narges [1 ]
Yazdanparast, Razieh [1 ]
Molaei, Mahsa [2 ,3 ]
机构
[1] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran
[2] Shahid Beheshti Univ, Res Ctr Gastroenterol & Liver Dis, Tehran, Iran
[3] Acad Med Sci, Tehran, Iran
关键词
EtOAc; MCD diet; nonalcoholic steatohepatitis (NASH); oxidative stress; Teucrium polium; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; ANTIOXIDANT ACTIVITY; IN-VITRO; GLUTATHIONE; HEPATITIS; EXTRACT;
D O I
10.1111/j.1478-3231.2009.02033.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background In this study, we tried to evaluate whether the ethyl acetate (EtOAc) extract of Teucrium polium, with a high antioxidant activity, is able to prevent the incidence of nonalcoholic steatohepatitis. Methods Nonalcoholic steatohepatitis was induced in male N-Mary rats using a methionine/choline-deficient (MCD) diet. Rats were given normal diet (A), normal diet+EtOAc extract (B), MCD diet (C) and MCD diet+EtOAc (D). Results The MCD diet led to grade 1 liver steatosis, inflammation and ballooning degeneration. In group D, these factors abated to grade 0 in 80% of the rats. In groups receiving the EtOAc extract, lipoprotein profiles had significantly improved relative to those not receiving the extract. Also, a dramatic reduction was observed in the sera alkaline phosphatase, aspartate aminotransferase and alanine aminoteransferase activities. The activities of the liver superoxide dismutase, glutathione peroxidase and glutathione reductase enzymes were also enhanced. Conclusion The EtOAc extract could reverse the adverse effects of the MCD diet.
引用
收藏
页码:1216 / 1221
页数:6
相关论文
共 26 条
[1]
Therapeutic effects of Teucrium polium extract on oxidative stress in pancreas of streptozotocin-induced diabetic rats [J].
Ardestani, A. ;
Yazdanparast, R. ;
Jamshidi, Sh. .
JOURNAL OF MEDICINAL FOOD, 2008, 11 (03) :525-532
[2]
Inhibitory effects of ethyl acetate extract of Teucrium polium on in vitro protein glycoxidation [J].
Ardestani, Amin ;
Yazdanparast, Razieh .
FOOD AND CHEMICAL TOXICOLOGY, 2007, 45 (12) :2402-2411
[3]
AUTORE G, 1984, PHARMACOL RES COMMUN, V16, P21
[4]
Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course [J].
Cortez-Pinto, H ;
Camilo, ME .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) :1089-1104
[5]
Pathogenesis of steatohepatitis [J].
Day, CP .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2002, 16 (05) :663-678
[6]
Steatohepatitis: A tale of two "hits"? [J].
Day, CP ;
James, OFW .
GASTROENTEROLOGY, 1998, 114 (04) :842-845
[7]
Day CP, 2002, J GASTROEN HEPATOL, V17, P377, DOI DOI 10.1046/J.1440-1746.17.S3.31.X
[8]
Lessons from animal models of NASH [J].
Diehl, AM .
HEPATOLOGY RESEARCH, 2005, 33 (02) :138-144
[9]
Hübscher SG, 2004, EUR J GASTROEN HEPAT, V16, P1107
[10]
BROMOBENZENE-INDUCED LIVER NECROSIS - PROTECTIVE ROLE OF GLUTATHIONE AND EVIDENCE FOR 3,4-BROMOBENZENE OXIDE AS HEPATOTOXIC METABOLITE [J].
JOLLOW, DJ ;
MITCHELL, JR ;
ZAMPAGLIONE, N ;
GILLETTE, JR .
PHARMACOLOGY, 1974, 11 (03) :151-169